Intermune - Almost Done

Roche’s (Ticker: RHHBY) acquisition of Intermune (Ticker: ITMN) is pretty much a done deal now. The company received all of the required regulatory approvals as of yesterday as we head toward to expiration of the tender offer on September 26^th.  I’ll most likely hang on and let the options expire in October unless I see something more compelling to free up some buying power.